| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |